相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Identification of RPS14 as a 5q- syndrome gene by RNA interference screen
Benjamin L. Ebert et al.
NATURE (2008)
MLL translocations, histone modifications and leukaemia stem-cell development
Andrei V. Krivtsov et al.
NATURE REVIEWS CANCER (2007)
JMJD6 is a histone arginine demethylase
Bingsheng Chang et al.
SCIENCE (2007)
Safety and clinical activity of the combination of 5-azacytidine, valproic acid, and all-trans retinoic acid in acute myeloid leukemia and myelodysplastic syndrome
Andres O. Soriano et al.
BLOOD (2007)
Protein arginine-methyltransferase-dependent oncogenesis
Ngai Cheung et al.
NATURE CELL BIOLOGY (2007)
Time-dependent prognostic scoring system for predicting survival and leukemic evolution in myelodysplastic syndromes
Luca Malcovati et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Haploinsufficiency of EGR1, a candidate gene in the del(5q), leads to the development of myeloid disorders
John M. Joslin et al.
BLOOD (2007)
Lenalidomide inhibits the malignant clone and up-regulates the SPARC gene mapping to the commonly deleted region in 5q-syndrome patients
Andrea Pellagatti et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
NUP98-NSD1 links H3K36 methylation to Hox-A gene activation and leukaemogenesis
Gang G. Wang et al.
NATURE CELL BIOLOGY (2007)
Mouse embryonic stem cells that express a NUP98-HOXD13 fusion protein are impaired in their ability to differentiate and can be complemented by BCR-ABL
C. Slape et al.
LEUKEMIA (2007)
DNA methylation as a therapeutic target in cancer
Jean-Pierre J. Issa
CLINICAL CANCER RESEARCH (2007)
CD34+hematopoietic stem-progenitor cell microRNA expression and function: A circuit diagram of differentiation control
Robert W. Georgantas et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Detrimental effect of natural killer cell alloreactivity in T-replete hematopoietic cell transplantation (HCT) for leukemia patients
Joel Y. Sun et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2007)
Chromosome 5q deletion and epigenetic suppression of the gene encoding alpha-catenin (CTNNA1) in myeloid cell transformation
Ting Xi Liu et al.
NATURE MEDICINE (2007)
L3MBTL1, a histone-methylation-dependent chromatin lock
Patrick Trojer et al.
CELL (2007)
Results of a randomized study of 3 schedules of low-dose decitabine in higher-risk myelodysplastic syndrome and chronic myelomonocytic leukemia
Hagop Kantarjian et al.
BLOOD (2007)
MicroRNAs: regulators of gene expression and cell differentiation
Ramesh A. Shivdasani
BLOOD (2006)
Lenalidomide in the myelodysplastic syndrome with chromosome 5q deletion
Alan List et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Refractory anemia with ringed sideroblasts associated with marked thrombocytosis (RARS-T), another myeloproliferative condition characterized by JAK2 V617F mutation
Hadrian Szpurka et al.
BLOOD (2006)
Enhancement of ligand-dependent activation of human natural killer T cells by lenalidomide: therapeutic implications
David H. Chang et al.
BLOOD (2006)
Clinical application and proposal for modification of the International Working Group (IWG) response criteria in myelodysplasia
Bruce D. Cheson et al.
BLOOD (2006)
Gene expression profiles of CD34+ cells in myelodysplastic syndromes:: involvement of interferon-stimulated genes and correlation to FAB subtype and karyotype
Andrea Pellagatti et al.
BLOOD (2006)
Combined DNA methyltransferase and histone deacetylase inhibition in the treatment of myeloid neoplasms
SD Gore et al.
CANCER RESEARCH (2006)
Prevalence of the activating JAK2 tyrosine kinase mutation V617F in the Budd-Chiari syndrome
Raj K. Patel et al.
GASTROENTEROLOGY (2006)
Hyperactivation of the RAS signaling pathway in myelodysplastic syndrome with AML1/RUNX1 point mutations
H Niimi et al.
LEUKEMIA (2006)
Reactive oxygen species act through p38 MAPK to limit the lifespan of hematopoietic stem cells
K Ito et al.
NATURE MEDICINE (2006)
Pilot study of combination transcriptional modulation therapy with sodium phenylbutyrate and 5-azacytidine in patients with acute myeloid leukemia or myelodysplastic syndrome
P Maslak et al.
LEUKEMIA (2006)
The diverse functions of histone lysine methylation
C Martin et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2005)
Emerging data on IMiDs in the treatment of myelodysplastic syndromes (MDS)
AF List
SEMINARS IN ONCOLOGY (2005)
Long-term outcome of treatment of anemia in MDS with erythropoietin and G-CSF
M Jädersten et al.
BLOOD (2005)
Loss of Runx1 perturbs adult hematopoiesis and is associated with a myeloproliferative phenotype
JD Growney et al.
BLOOD (2005)
NUP98-HOXD13 transgenic mice develop a highly penetrant, severe myelodysplastic syndrome that progresses to acute leukemia
YW Lin et al.
BLOOD (2005)
Impaired maturation of myeloid progenitors in mice lacking novel Polycomb group protein MBT-1
S Arai et al.
EMBO JOURNAL (2005)
5-Aza-2'-deoxycytidine induces p21WAF expression by demethylation of p73 leading to p53-independent apoptosis in myeloid leukemia
K Schmelz et al.
INTERNATIONAL JOURNAL OF CANCER (2005)
The evolving role of pemetrexed (Alimta) in lung cancer
MA Socinski et al.
SEMINARS IN ONCOLOGY (2005)
Management of anemia associated with myelodysplastic syndrome
E Hellström-Lindberg
SEMINARS IN HEMATOLOGY (2005)
A retrospective analysis of myelodysplastic syndromes with thrombocytosis:: reclassification of the cases by WHO proposals
AI Cabello et al.
LEUKEMIA RESEARCH (2005)
When epigenetics kills: MLL fusion proteins in leukemia
RK Slany
HEMATOLOGICAL ONCOLOGY (2005)
Efficacy of lenalidomide in myelodysplastic syndromes
A List et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Role of nucleophosmin in embryonic development and tumorigenesis
S Grisendi et al.
NATURE (2005)
Timeline - The evolution of thalidomide and its IMiD derivatives as anticancer agents
JB Bartlett et al.
NATURE REVIEWS CANCER (2004)
Phase II study of R115777, a farnesyl transferase inhibitor, in myelodysplastic syndrome
R Kurzrock et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
RAS, FLT3, and TP53 mutations in therapy-related myeloid malignancies with abnormalities of chromosomes 5 and 7
LE Side et al.
GENES CHROMOSOMES & CANCER (2004)
EVI1 induces myelodysplastic syndrome in mice
S Buonamici et al.
JOURNAL OF CLINICAL INVESTIGATION (2004)
Histone demethylation mediated by the nuclear arnine oxidase homolog LSD1
YJ Shi et al.
CELL (2004)
Focus on myeloproliferative diseases and myelodysplastic syndromes
RA Van Etten et al.
CANCER CELL (2004)
Regulation of oxidative stress by ATM is required for self-renewal of haematopoietic stem cells
K Ito et al.
NATURE (2004)
Epigenetics in human disease and prospects for epigenetic therapy
G Egger et al.
NATURE (2004)
Molecular mechanisms of leukemogenesis by AML1/EVI-1
K Mitani
ONCOGENE (2004)
Effects of the leukemia-associated AML1-ETO protein on hematopoietic stem and progenitor cells
SD Nimer et al.
ONCOGENE (2004)
Point mutations in the RUNX1/AML1 gene:: another actor in RUNX leukemia
M Osato
ONCOGENE (2004)
Mechanism of leukemogenesis by the inv(16) chimeric gene CBFB/PEBP2B-MHY11
K Shigesada et al.
ONCOGENE (2004)
A simple method to predict response to immunosuppressive therapy in patients with myelodysplastic syndrome
Y Saunthararajah et al.
BLOOD (2003)
EZH2 is a marker of aggressive breast cancer and promotes neoplastic transformation of breast epithelial cells
CG Kleer et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Severe and selective deficiency of interferon-γ-producing invariant natural killer T cells in patients with myelodysplastic syndromes
S Fujii et al.
BRITISH JOURNAL OF HAEMATOLOGY (2003)
Induction of acute myeloid leukemia in mice by the human leukemia-specific fusion gene NUP98-HOXD13 in concert with Meis1
N Pineault et al.
BLOOD (2003)
The human L(3)MBT polycomb group protein is a transcriptional repressor and interacts physically and functionally with TEL (ETV6)
P Boccuni et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
A tyrosine kinase created by fusion of the PDGFRA and FIP1L1 genes as a therapeutic target of imatinib in idiopathic hypereosinophilic syndrome
J Cools et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
The myelodysplastic syndrome(s): a perspective and review highlighting current controversies
DP Steensma et al.
LEUKEMIA RESEARCH (2003)
Implications of somatic mutations in the AML1 gene in radiation-associated and therapy-related myelodysplastic syndrome/acute myeloid leukemia
H Harada et al.
BLOOD (2003)
Guidelines for the diagnosis and therapy of adult myelodysplastic syndromes
D Bowen et al.
BRITISH JOURNAL OF HAEMATOLOGY (2003)
MLL targets SET domain methyltransferase activity to Hox gene promoters
TA Milne et al.
MOLECULAR CELL (2002)
The polycomb group protein EZH2 is involved in progression of prostate cancer
S Varambally et al.
NATURE (2002)
The World Health Organization (WHO) classification of the myeloid neoplasms
JW Vardiman et al.
BLOOD (2002)
Intracellular interferon-γ in circulating and marrow T cells detected by flow cytometry and the response to immunosuppressive therapy in patients with aplastic anemia
E Sloand et al.
BLOOD (2002)
Randomized controlled trial of azacitidine in patients with the myelodysplastic syndrome: A study of the cancer and leukemia group B
LR Silverman et al.
JOURNAL OF CLINICAL ONCOLOGY (2002)
Impact of azacytidine on the quality of life of patients with myelodysplastic syndrome treated in a randomized phase III trial: A cancer and leukemia group B study
AB Kornblith et al.
JOURNAL OF CLINICAL ONCOLOGY (2002)
A novel gene, NSD1, is fused to NUP98 in the t(5;11)(q35;p15.5) in de novo childhood acute myeloid leukemia
RJ Jaju et al.
BLOOD (2001)
Identification of myelodysplastic syndrome-specific genes by DNA microarray analysis with purified hematopoietic stem cell fraction
A Miyazato et al.
BLOOD (2001)
Identification of candidate genes on chromosome band 20q12 by physical mapping of translocation breakpoints found in myeloid leukemia cell lines
D MacGrogan et al.
ONCOGENE (2001)
Coexpression of BMI-1 and EZH2 polycomb-group proteins is associated with cycling cells and degree of malignancy in B-cell non-Hodgkin lymphoma
FJ van Kemenade et al.
BLOOD (2001)
Histone methylation versus histone acetylation: new insights into epigenetic regulation
JC Rice et al.
CURRENT OPINION IN CELL BIOLOGY (2001)
Erythroid defects and increased retrovirally-induced tumor formation in Evi1 transgenic mice
D Louz et al.
LEUKEMIA (2000)
A niche maintaining germ line stem cells in the Drosophila ovary
T Xie et al.
SCIENCE (2000)
Candidate tumor suppressor RIZ is frequently involved in colorectal carcinogenesis
RB Chadwick et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
分享论文
